ÂÜÀòÂÒÂ×

Dhiraj Gambhire, MD, MPH, currently serves as the Global Clinical Lead for Enhertu (Breast) and holds the title of Executive Medical Director at Daiichi Sankyo, Inc. since April 2020, focusing on clinical development for breast cancer indications. Prior to this role, Dhiraj served as Senior Medical Director at Pfizer, specializing in Enhertu (HER2 low breast cancer) and Immuno-Oncology from October 2015 to April 2020. Dhiraj's experience includes positions as Clinical Development Physician at Boston Biomedical, and a Graduate Research Assistant at MD Anderson Cancer Center. Earlier career roles include an internship in Early Clinical Development at Biogen and a Clinical Development Physician at Zydus Cadila. Dhiraj's educational background includes an MPH in Biostatistics from The University of Texas Health Science Center at Houston, an MD from Government Medical College in India, and an MBBS from NDMVPS Medical College, Nashik, India.